Boothbay Fund Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-34,710
| Closed | -$98.9K | – | 1734 |
|
|
2024
Q3 | $98.9K | Hold |
34,710
| – | – | ﹤0.01% | 1264 |
|
|
2024
Q2 | $78.1K | Sell |
34,710
-8,490
| -20% | -$19.1K | ﹤0.01% | 1212 |
|
|
2024
Q1 | $95.5K | Buy |
+43,200
| New | +$95.5K | ﹤0.01% | 1249 |
|
|
2022
Q2 | – | Sell |
-32,414
| Closed | -$83K | – | 2350 |
|
|
2022
Q1 | $83K | Buy |
32,414
+1,984
| +7% | +$5.08K | ﹤0.01% | 1741 |
|
|
2021
Q4 | $89K | Buy |
+30,430
| New | +$89K | ﹤0.01% | 1563 |
|
|
2020
Q3 | – | Sell |
-19,190
| Closed | -$51K | – | 1135 |
|
|
2020
Q2 | $51K | Buy |
19,190
+7,390
| +63% | +$19.6K | ﹤0.01% | 787 |
|
|
2020
Q1 | $23K | Sell |
11,800
-1,952
| -14% | -$3.81K | ﹤0.01% | 711 |
|
|
2019
Q4 | $97K | Buy |
+13,752
| New | +$97K | 0.01% | 661 |
|